Markets Insider: Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Skagit Valley Herald: Revalesio to Present Advances in Stroke Treatment with RNS60 at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Revalesio to Present Advances in Stroke Treatment with RNS60 at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting
Several experimental prostate cancer drugs have produced striking results in early-stage clinical trials, with at least one agent shown to shrink tumors in patients whose disease had resisted every ...
The following is adapted from materials compiled by the American Society of Clinical Hypnosis, an academic and professional group widely regarded as a source of legitimate scientific and clinical ...
Business Wire: Massive Bio Collaborates with the American Cancer Society to Accelerate Equitable Access to Cancer Clinical Trials
BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio today emphasized the nationwide expansion of ACS ACTS® (Access to Clinical Trials and Support), the American Cancer Society’s program designed to help ...
Massive Bio Collaborates with the American Cancer Society to Accelerate Equitable Access to Cancer Clinical Trials
Business Wire: A2 Bio Highlights Progress of CAR T-Cell Clinical Programs in Three Poster Presentations during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
A2 Bio Highlights Progress of CAR T-Cell Clinical Programs in Three Poster Presentations during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Business Wire: Alto Neuroscience Presents Data at the 2025 American Society of Clinical Psychopharmacology Annual Meeting Reinforcing Safety and Tolerability Profile for ALTO-300 in Major ...